ArticleTranslational oncology2025

Lnc-PHF3-3 aggravates the chemoresistance of osteosarcoma cells to doxorubicin via the miR-142-3p/HMGB1 axis.

Jingyi Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.